# FDA Inspection 1210742 - Granules India Limited - June 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/granules-india-limited/3437d3fd-8194-43cf-aef3-b72fb024d8c3
Source feed: FDA_Inspections

> FDA Inspection 1210742 for Granules India Limited on June 30, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210742
- Company Name: Granules India Limited
- Inspection Date: 2023-06-30
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 956160 - 2015-12-18](https://www.keypedia.com/records/fda_inspections/granules-india-limited/efec4f74-99e6-4568-947c-cceaa43f4d33)
- [FDA Inspection 842227 - 2013-06-14](https://www.keypedia.com/records/fda_inspections/granules-india-limited/41183ae7-f0e8-4bae-a6fb-a59b48dc2ca5)

Company: https://www.keypedia.com/companies/granules-india-limited/e1857df6-77c2-4402-9c0a-41f15fb61070

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c